Researchers mimic mussels for delivery 'glue'; HGH nasal spray passes second clinical trial;

> Researchers at Northwestern University are using a material based on the glue that holds mussels to rocks underwater to help during surgical repair and polymer-based drug delivery. Release

> Critical Pharmaceuticals completed a second clinical study of its CP024 human growth hormone nasal spray, an alternative to injections for children and adults with growth disorders. Release

> New Jersey-based mPhase Technologies filed a patent application for a novel drug delivery system based on its Smart Surface technology, which enables the precise control of a fluid on a nano-structured surface. Release

> Mylan ($MYL) entered into an agreement with Biocon for the global development and commercialization of Biocon's insulin analog products with a potential market of $11.5 billion. Biocon is also in the market with Bristol-Myers Squibb ($BMY) and the company's pursuit of oral insulin approval. Story

> Gamida Cell saw successful results in its Phase I/II study of NiCord, stem cells derived from the umbilical cord that are designed to treat patients with high-risk blood disorders. Release